← Back
$EW All transactions

Edwards Lifesciences Corp

▼ SELL 10b5-1 Plan

$ Value

$83K

Shares

1,019

Price

$81

Filed

Apr 6

Insider

Name

Lippis Daniel J.

Title

CVP, TAVR

CIK

0002004380

Roles

Officer

Transaction Details

Transaction Date

2026-04-06

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

33,934

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025. | This transaction was executed in multiple trades at prices ranging from $80.64 to $81.07. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Filing Info

Accession No.

0001225208-26-004422

Form Type

4

Issuer CIK

0001099800

Lippis Daniel J.'s History

Date Ticker Type Value
2026-04-06 EW M $60K
2026-04-06 EW $83K
2026-04-06 EW M $0
2026-03-11 EW M $60K
2026-03-11 EW $87K
2026-03-11 EW M $0
2026-02-22 EW F $34K
2026-02-17 EW F $15K
2026-02-16 EW F $20K
2026-02-12 EW A $0

Other Insiders at EW (90d)

Insider Bought Sold Last
BOBO DONALD E JR
CVP,Strategy/Corp Development
$4.8M 2026-04-02
Ullem Scott B.
CVP, Chief Financial Officer
$2.1M 2026-04-09
Zovighian Bernard J
CEO
$1.7M 2026-02-13
Lippis Daniel J.
CVP, TAVR
$87K 2026-04-06
Dahl Andrew M.
SVP, Corporate Controller
2026-02-22